NO933261L - Blanding til forsterkning av immunforsvaret - Google Patents

Blanding til forsterkning av immunforsvaret

Info

Publication number: NO933261L
Authority: NO; Norway
Prior art keywords: antigen; immunogen; forms; strengthening; mixture
Prior art date: 1992-09-14

Application number

NO933261A

Other languages

English (en)

Other versions

NO313178B1 (no

NO933261D0 (no

Inventor

Robert S Becker

Karen Biscardi

Laura Ferguson

Lorne Franklin Erdile

Original Assignee

Connaught Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-09-14

Filing date

1993-09-13

Publication date

1994-03-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25479200&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO933261(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1993-09-13 Application filed by Connaught Lab filed Critical Connaught Lab

1993-09-13 Publication of NO933261D0 publication Critical patent/NO933261D0/no

1994-03-15 Publication of NO933261L publication Critical patent/NO933261L/no

2002-08-26 Publication of NO313178B1 publication Critical patent/NO313178B1/no

Links

239000000203 mixture Substances 0.000 title abstract 3
210000000987 immune system Anatomy 0.000 title 1
238000005728 strengthening Methods 0.000 title 1
239000000427 antigen Substances 0.000 abstract 7
102000036639 antigens Human genes 0.000 abstract 7
108091007433 antigens Proteins 0.000 abstract 7
230000002163 immunogen Effects 0.000 abstract 4
230000028993 immune response Effects 0.000 abstract 2
239000000126 substance Substances 0.000 abstract 1
241000712461 unidentified influenza virus Species 0.000 abstract 1
230000003612 virological effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6018—Lipids, e.g. in lipopeptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Pulmonology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Jib Cranes (AREA)
Enzymes And Modification Thereof (AREA)
Medicines Containing Plant Substances (AREA)
Radar Systems Or Details Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

NO19933261A 1992-09-14 1993-09-13 Sammensetning til fremskaffelse av en immunrespons mot et antigen hos et dyr, sett til anvendelse derav, samt anvendelse aven först opplöselig form av et antigen og en andre uopplöseligform av antigenet ved fremstilling av sammensetningen elle NO313178B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US94317392A	1992-09-14	1992-09-14

Publications (3)

Publication Number	Publication Date
NO933261D0 NO933261D0 (no)	1993-09-13
NO933261L true NO933261L (no)	1994-03-15
NO313178B1 NO313178B1 (no)	2002-08-26

Family

ID=25479200

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19933261A NO313178B1 (no)	1992-09-14	1993-09-13	Sammensetning til fremskaffelse av en immunrespons mot et antigen hos et dyr, sett til anvendelse derav, samt anvendelse aven först opplöselig form av et antigen og en andre uopplöseligform av antigenet ved fremstilling av sammensetningen elle

Country Status (15)

Country	Link
US (4)	US5662909A (no)
EP (1)	EP0588578B2 (no)
JP (1)	JP2512689B2 (no)
AT (1)	ATE187338T1 (no)
AU (1)	AU677592B2 (no)
CA (1)	CA2105629A1 (no)
DE (1)	DE69327214T3 (no)
DK (1)	DK0588578T4 (no)
ES (1)	ES2141750T5 (no)
FI (1)	FI110234B (no)
GR (1)	GR3032543T3 (no)
IL (2)	IL106968A (no)
NO (1)	NO313178B1 (no)
PT (1)	PT588578E (no)
ZA (1)	ZA936629B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6967088B1 (en) *	1995-03-16	2005-11-22	Allergan, Inc.	Soluble recombinant botulinum toxin proteins
US6251405B1 (en) *	1995-06-07	2001-06-26	Connaught Laboratories, Inc.	Immunological combination compositions and methods
ZA964896B (en) *	1995-06-07	1997-01-08	Connaught Lab	Expression of lipoproteins
ATE384795T1 (de) *	1998-12-31	2008-02-15	Novartis Vaccines & Diagnostic	Modifizierte hiv env polypeptide
EP1141314A2 (en) *	1998-12-31	2001-10-10	Chiron Corporation	Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
AU2221600A (en)	1998-12-31	2000-07-31	Chiron Corporation	Improved expression of hiv polypeptides and production of virus-like particles
US7935805B1 (en) *	1998-12-31	2011-05-03	Novartis Vaccines & Diagnostics, Inc	Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
US20050106137A1 (en) *	2000-05-05	2005-05-19	Stephen Grimes	Chimeric peptide immunogens
DK2301524T3 (da) *	2000-12-27	2013-07-15	Gilead Sciences Inc	Inhalerbar aztreonam uden arginin til behandling og forebyggelse af bakterielle lungeinfektioner
EP1409694A4 (en) *	2001-07-05	2006-02-08	Chiron Corp	POLYNUCLEOTIDES ENCODING ANTIGENIC POLYPEPTIDES OF HIV SUBTYPE B AND / OR SUBTYPE C, POLYPEPTIDES AND USES THEREOF
AU2002320314A1 (en)	2001-07-05	2003-01-21	Chiron, Corporation	Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US20030170614A1 (en) *	2001-08-31	2003-09-11	Megede Jan Zur	Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
CA2458995C (en) *	2001-08-31	2013-04-30	Chiron Corporation	Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
US7211258B2 (en) *	2002-04-10	2007-05-01	Protalex, Inc.	Protein A compositions and methods of use
US7425331B2 (en) *	2002-04-10	2008-09-16	Protalex, Inc.	Protein A methods of use
US6814729B2 (en)	2002-06-27	2004-11-09	Technovision Gmbh	Laser vision correction apparatus and control method
WO2011119920A2 (en)	2010-03-25	2011-09-29	Oregon Health & Science University	Cmv glycoproteins and recombinant vectors
ES2667425T3 (es)	2011-06-10	2018-05-10	Oregon Health & Science University	Glucoproteínas y vectores recombinantes de CMV
AU2012216792A1 (en)	2011-09-12	2013-03-28	International Aids Vaccine Initiative	Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en)	2011-10-27	2013-05-01	Christopher L. Parks	Viral particles derived from an enveloped virus
EP2679596B1 (en)	2012-06-27	2017-04-12	International Aids Vaccine Initiative	HIV-1 env glycoprotein variant
US20150065381A1 (en)	2013-09-05	2015-03-05	International Aids Vaccine Initiative	Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en)	2013-10-07	2017-05-31	International Aids Vaccine Initiative	Soluble hiv-1 envelope glycoprotein trimers
US10174292B2 (en)	2015-03-20	2019-01-08	International Aids Vaccine Initiative	Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (en)	2015-03-23	2016-09-28	International Aids Vaccine Initiative	Soluble hiv-1 envelope glycoprotein trimers

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4496538A (en) *	1982-07-06	1985-01-29	Connaught Laboratories, Inc.	Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
US4619828A (en) *	1982-07-06	1986-10-28	Connaught Laboratories, Inc.	Polysaccharide exotoxoid conjugate vaccines
GB8610983D0 (en) *	1986-05-06	1986-06-11	Connaught Lab	Enhancement of antigen immunogenicity
US4946676A (en) *	1986-08-27	1990-08-07	De Staat Der Nederlanden	Vaccine comprising an immunogenic protein and, as an adjuvant, a substantially non-immunogenic, sequentially homologous peptide
EP0270295A3 (en) *	1986-12-03	1989-08-02	Connaught Laboratories Limited	Conjugate vaccine
DK425789A (da) *	1988-08-31	1990-03-01	Smithkline Beecham Corp	Vaccinale polypeptider
JPH0678245B2 (ja) *	1989-07-04	1994-10-05	東興薬品工業株式会社	鼻腔内噴霧投与用インフルエンザワクチンゲル製剤
SG122738A1 (en) *	1990-06-15	2006-06-29	Univ Yale	Compositions and methods for the prevention and diagnosis of lyme disease
CA2121121C (en) *	1991-10-18	2003-06-10	Lorne F. Erdile	Preparation of recombinant borrelia proteins

1993
- 1993-09-07 CA CA002105629A patent/CA2105629A1/en not_active Abandoned
- 1993-09-08 ZA ZA936629A patent/ZA936629B/xx unknown
- 1993-09-08 AU AU46226/93A patent/AU677592B2/en not_active Ceased
- 1993-09-10 IL IL10696893A patent/IL106968A/en not_active IP Right Cessation
- 1993-09-13 NO NO19933261A patent/NO313178B1/no unknown
- 1993-09-13 ES ES93307185T patent/ES2141750T5/es not_active Expired - Lifetime
- 1993-09-13 DK DK93307185T patent/DK0588578T4/da active
- 1993-09-13 EP EP93307185A patent/EP0588578B2/en not_active Expired - Lifetime
- 1993-09-13 DE DE69327214T patent/DE69327214T3/de not_active Expired - Fee Related
- 1993-09-13 PT PT93307185T patent/PT588578E/pt unknown
- 1993-09-13 AT AT93307185T patent/ATE187338T1/de not_active IP Right Cessation
- 1993-09-14 JP JP5229041A patent/JP2512689B2/ja not_active Expired - Lifetime
- 1993-09-14 FI FI934013A patent/FI110234B/fi not_active IP Right Cessation
1995
- 1995-02-08 US US08/385,587 patent/US5662909A/en not_active Expired - Fee Related
- 1995-06-06 US US08/470,278 patent/US5837264A/en not_active Expired - Lifetime
1997
- 1997-02-18 US US08/801,152 patent/US5853736A/en not_active Expired - Fee Related
1998
- 1998-11-17 US US09/193,682 patent/US6024963A/en not_active Expired - Lifetime
1999
- 1999-05-23 IL IL13007599A patent/IL130075A0/xx unknown
2000
- 2000-02-02 GR GR20000400239T patent/GR3032543T3/el unknown

Also Published As

Publication number	Publication date
EP0588578B2 (en)	2005-04-13
US5837264A (en)	1998-11-17
JPH06192125A (ja)	1994-07-12
ATE187338T1 (de)	1999-12-15
US5662909A (en)	1997-09-02
DE69327214D1 (de)	2000-01-13
ES2141750T5 (es)	2005-12-01
ZA936629B (en)	1994-03-30
CA2105629A1 (en)	1994-03-15
PT588578E (pt)	2000-05-31
FI934013A0 (fi)	1993-09-14
US6024963A (en)	2000-02-15
GR3032543T3 (en)	2000-05-31
JP2512689B2 (ja)	1996-07-03
ES2141750T3 (es)	2000-04-01
NO313178B1 (no)	2002-08-26
EP0588578B1 (en)	1999-12-08
IL106968A0 (en)	1993-12-28
DE69327214T3 (de)	2005-12-01
AU4622693A (en)	1994-03-24
FI110234B (fi)	2002-12-31
US5853736A (en)	1998-12-29
DK0588578T4 (da)	2005-07-25
DE69327214T2 (de)	2000-09-07
IL106968A (en)	1999-10-28
NO933261D0 (no)	1993-09-13
DK0588578T3 (da)	2000-03-27
FI934013L (fi)	1994-03-15
AU677592B2 (en)	1997-05-01
IL130075A0 (en)	2000-02-29
EP0588578A1 (en)	1994-03-23

Publication	Publication Date	Title
NO933261D0 (no)	1993-09-13	Blanding til forsterkning av immunforsvaret
WO1991002805A3 (en)	1991-04-18	Recombinant retroviruses delivering vector constructs to target cells
IL89701A0 (en)	1989-09-28	Recombinant retroviruses,method for the production thereof and pharmaceutical composition containing the same
ES2089316T3 (es)	1996-10-01	Agente viral asociado con la enfermedad porcina misteriosa (mystery swine desease).
DK0869814T3 (da)	2005-10-17	Stabilisatorer til levende vacciner
NO20001768D0 (no)	2000-04-06	Viruskapsomervaksine, fremgangsmåte til fremstilling samt anvendelse derav
IS4518A (is)	1999-01-10	Nýtt lyfjaform fyrir bóluefni
EP0090581A3 (en)	1984-10-24	Small peptides with the specificity of foot and mouth disease viral antigens
KR950700758A (ko)	1995-02-20	비-이온성 계면활성제 소포를 함유하는 백신(Vaccines containing non ionic surfactant vesicles)
MX9401225A (es)	1994-08-31	Composicion de vacuna para prevenir la infeccion con influenza en humanos y metodo para su preparacion.
FI823021A7 (fi)	1983-03-03	Tuotteet, jotka osoittavat hepatitis B virus e antigeenin antigeenisuuden ja menetelmät näiden antigeenien vavalmistamiseksi.
BR9907883A (pt)	2000-11-14	Composição de vacina, processo para eliciar uma resposta imune a um antìgeno de vìrus de herpes simplex, e, composição imunogênica
DK0789590T3 (da)	2002-11-04	Chitosaninduceret immunforstærkning
PT792165E (pt)	2004-02-27	Composicoes imunogenicas
ES2056780T1 (es)	1994-10-16	Un procedimiento para el aislamiento de virus de hav.
ATE318300T1 (de)	2006-03-15	Isolierte stämme von staphylococcus aureus und daraus hergestellte impfstoffe
FI902814A0 (fi)	1990-06-05	Proteiner, vaccin och nukleinsyror.
AU8501191A (en)	1992-03-02	Cross-reactive influenza a immunization
EP0563288A4 (en)	1994-08-24	Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines
DE69422980D1 (de)	2000-03-16	Extrakte von Piliostigma thonningii, deren Verwendung und diese enthaltende Zubereitungen
Hayami et al.	1979	CELL MEDIATED IMMUNITY AGAINST AVIAN VIRUS-INDUCED TUMOR CELLS